Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis
A RANDOMIZED, OPEN-LABEL, TWO-PERIOD STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ETANERCEPT ON SKIN AND JOINT DISEASE IN PSORIASIS SUBJECTS WITH PSORIATIC ARTHRITIS
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Buenos Aires, Argentina, C1199ABD
- Hospital Italiano de Buenos Aires
-
Buenos Aires, Argentina, C1001AFA
- Hospital General de Agudos
-
Buenos Aires, Argentina, C1001AFA
- Hospital Italiano de Buenos Aires
-
Buenos Aires, Argentina, C1014ADB
- CEMIC
-
Buenos Aires, Argentina, C1155ADO
- Hospital General de Agudos
-
Buenos Aires, Argentina, C1221ACJ
- Instituto de Medicina Cutanea
-
-
Buenos Aires
-
Palomar, Buenos Aires, Argentina, 1684
- Hospital A Posadas
-
-
-
-
-
Fitzroy, Australia, VIC 3065
- St Vincent's Hospital VIC
-
-
New South Wales
-
Liverpool, New South Wales, Australia, 2170
- Goulburn Street Medical Centre
-
-
-
-
-
Wien, Austria, 1030
- Krankenhaus Rudolfsstiftung
-
-
SM
-
Graz, SM, Austria, 8036
- Universitaetsklinik Graz
-
-
-
-
-
Gent, Belgium, 9000
- Universitair Ziekenhuis Gent
-
Liege, Belgium, 4000
- CHU Liège
-
-
-
-
-
Bogota, Colombia
- Centro Medico de la Sabana
-
-
Atlantico
-
Barranquilla, Atlantico, Colombia
- Centro Integral de Reumatología del Caribe S.A.S
-
-
-
-
-
Praha 2, Czechia, 128 50
- Revmatologicky Ustav
-
Uherske Hradiste, Czechia, 686 01
- Revmatologicka ambulance
-
-
Czech Republic
-
Zlin, Czech Republic, Czechia, 760 01
- Centrum Rehabilitace
-
-
-
-
-
Copenhagen, Denmark, DK-2400
- Bispebjerg University Hospital
-
Hellerup, Denmark, 2900
- Gentofte University Hospital
-
Hørsholm, Denmark, 2970
- Hørsholm hospital
-
Odense C, Denmark, 5000
- Odense University Hospital
-
Roskilde, Denmark, 4000
- University of Copenhagen - Roskilde Hospital
-
-
-
-
-
Helsinki, Finland, FIN-00100
- Mehiläinen Terveyspalvelut Oy Forum
-
Tampere, Finland, 33100
- Tampereen Reumatoismisto
-
Turku, Finland, 20100
- Iho ja Allergiapulssi
-
-
-
-
-
Belgrade, Former Serbia and Montenegro, 11000
- Institute of Rheumatology Belgrade
-
Niska Banja, Former Serbia and Montenegro, 18205
- Institute of Rheumatology Niska Banja
-
Novi Sad, Former Serbia and Montenegro, 21000
- Clinic for Dermatology and Clinic for Medical Rehabilitation
-
Zemun, Former Serbia and Montenegro, 11080
- Clinical Center Zemun
-
-
-
-
-
Bordeaux, France, 33075
- Hopital Saint André
-
Brest cedex 2, France, 29609
- Chu - Hôpital Morvan
-
Caen, France, 14000
- C.H.R.U. de Caen
-
Créteil cedex, France, 94000
- Hopital Henri Mondor
-
Limoges, France, 87042
- CHU Dupuytren
-
Nice, France, 06200
- CHU de l Archet
-
Paris, France, 75018
- Hopital Bichat - Claude Bernard
-
Paris, France, 75010
- Hopital Saint Louis
-
Pierre Bénite, France, 69310
- Centre Hospitalier LYON SUD
-
Poitiers, France, 86000
- CHU La Miletrie
-
Rouen, France, 76000
- CHU - Hopital Charles Nicolle
-
Tours, France, 37044
- CHRU- Hôpital Trousseau
-
-
Cedex
-
Le Mans, Cedex, France, 72037
- Centre Hospitalier du Mans
-
-
-
-
-
Bad Bentheim, Germany, 48455
- Fachklinik Bad Bentheim
-
Berlin, Germany, 13125
- Klinische Forschung Berlin-Buch GmbH
-
Berlin, Germany, 10117
- Klinik fuer Dermatologie, Venerologie und Allergologie
-
Berlin, Germany, 10437
- Schonhauser Allee 71
-
Berlin, Germany, 10827
- Hautarztpraxis Dr. Margrit Simon
-
Berlin, Germany, 14059
- Schlossparkklinik Berlin
-
Bonn, Germany, 53105
- Klinik und Poliklinik für Dermatologie der Friedrich-Wilhelm
-
Erlangen, Germany, 91052
- Universitätsklinikum Hartmmannstrasse 14 Erlangen 91052
-
Frankfurt, Germany, 60596
- Klinikum der J.W. Goethe-Universität
-
Goettingen, Germany, D-37075
- Georg-August Universitaet Goettingen
-
Hamburg, Germany, 20354
- SCIderm GmbH Hamburg
-
Hamburg-Eilbek, Germany, 22081
- Allgemeines Krankenhaus Eilbek
-
Jena, Germany, 07740
- Friedrich-Schiller Universitat Jena
-
Jena, Germany, 07743
- Friedrich-Schiller Universitat Jena
-
Mahlow, Germany, 15831
- Bahnhofstr. 1
-
Muenchen, Germany, 80336
- Klinikum Innenstadt der Universitaet Muenchen
-
Muenchen, Germany, 80337
- Klinikum Innenstadt der Universitaet Muenchen
-
Osnabrueck, Germany, 49078
- Dermatologische Gemeinschaftspraxis Rosenbach
-
Rostock, Germany, 18059
- Praxis Dr. M. Richter
-
Wuerzburg, Germany, D-97070
- Universitaetsklinik Wuerzburg
-
Wuerzburg, Germany, D-97080
- Universitaetsklinik Wuerzburg
-
-
-
-
-
Athens, Greece, 16121
- University of Athens Andreas Syngros Hospital Athens, Greece
-
-
-
-
-
Budapest, Hungary, 1135
- Semmelweis University - Faculty of Health Sciences
-
Debrecen, Hungary, H-4004
- Debreceni Egyetem Orvos es Egeszsegtudomanyi Centrum
-
Miskolc, Hungary, 3529
- Miskolc Megyei Jogu Varos Onkormanyzata, Miskolci Egeszsegui
-
Pecs, Hungary, 7624
- Pécsi Tudományegyetem, ÁOK
-
Szeged, Hungary, 6720
- Medical University of Szeged
-
Szolnok, Hungary, 5400
- Hetenyi Geza Hospital
-
-
-
-
-
Brescia, Italy, 25100
- Azienda Ospedaliera Spedali Civili di Brescia
-
Cagliari, Italy, 09124
- Ospedale San Giovanni di Dio
-
Catania, Italy, 95124
- Clinica Dermatologica
-
Milano, Italy, 20161
- Ospedale Galeazzi
-
Parma, Italy, 43100
- Università degli Studi di Parma
-
Roma, Italy, 00161
- Policlinico Umberto I - Università La Sapienza
-
Roma, Italy
- Idi-Irccs
-
Siena, Italy, 53100
- Università degli Studi di Siena
-
-
-
-
-
Seoul, Korea, Republic of, 110-744
- Seoul National University Hospital
-
Seoul, Korea, Republic of, 138-736
- Asan Medical Centre
-
-
-
-
-
Mexico City, Mexico, 06700
- Cliditer S.A. de C.V.
-
-
Jalisco
-
Guadalajara, Jalisco, Mexico, 44620
- Unidad de Investigacion en
-
-
-
-
-
Maastricht, Netherlands, 6229 HX
- Academisch Ziekenhuis Maastricht
-
Vlissingen, Netherlands, 4382 EE
- Ziekenhuis Walcheren
-
Voorburg, Netherlands, 2275 CX
- Diaconessenhuis Voorburg
-
-
GA
-
Nijmegen, GA, Netherlands, 6525
- University Medical Center St. Radboud
-
-
THE Netherlands
-
Maastricht, THE Netherlands, Netherlands, 6229 HX
- Academisch Ziekenhuis Maastricht
-
-
-
-
-
Bydgoszcz, Poland
- Akad. Medyczna im L. Rydygiera
-
Lublin, Poland, 20-954
- Samodzielny Publiczny Szpital Kliniczny nr 4
-
Warszawa, Poland, 00-909
- Wojskowy Instytut Medyczny
-
Warszawa, Poland, 00710
- Zesp. Naukowo-Kliniczny IWOLANG, Uzdrowiskowa Klinika Dermat
-
-
-
-
-
Coimbra, Portugal, 3000-075
- Hospitais da Universidade de Coimbra
-
Porto, Portugal, 4050
- Hospital Santo Antonio
-
-
-
-
-
Riyadh, Saudi Arabia, 11211
- King Faisal Specialist Hospital & Research Centre
-
-
-
-
-
Barcelona, Spain, 08025
- Hospital de la Santa Cruz y San Pablo
-
Barcelona, Spain, 08003
- Hospital Nuestra Senora Del Mar
-
Madrid, Spain, 28037
- Hospital Ramon y Cajal
-
-
Cadiz
-
Puerto Real, Cadiz, Spain, 11510
- Hospital Universitario Puerto Real
-
-
Guipúzcua
-
San Sebastián, Guipúzcua, Spain, 20014
- Hospital de Donostia
-
-
Isalas Canarias
-
Las Palmas de Gran Canaria, Isalas Canarias, Spain, 35016
- Hospital Insular de Canarias
-
-
Madrid
-
Leganes, Madrid, Spain, 28911
- Hospital Severo Ochoa de Leganes
-
-
-
-
-
Jönköping, Sweden, 551 85
- Länssjukhuset Ryhov
-
Umeå, Sweden, 90185
- Umeå University Hospital
-
Uppsala, Sweden, 751 85
- Akademiska sjukhuset i Uppsala
-
-
-
-
-
Lausanne, Switzerland, 1011
- CHUV Lausanne
-
Zurich, Switzerland, 8091
- Universitätsspital Zürich
-
-
-
-
-
Taipei TOC, Taiwan, 100
- National Taiwan University Hospital
-
-
Taiwan, R.o.c.
-
Kaohsiung Hsiang, Taiwan, R.o.c., Taiwan, 833
- Chang Gung Memorial Hospital-KaohSiung
-
-
-
-
-
Ankara, Turkey, 06100
- Hacettepe University Medicine Faculty
-
-
-
-
-
Aberdeen, United Kingdom, AB15 4TN
- Aberdeen Royal Infirmary
-
Cardiff, United Kingdom, CF14 4XW
- University Hospital of Wales
-
Cardiff, United Kingdom, CF4 4XW
- University Hospital of Wales
-
London, United Kingdom, NW3 2QG
- The Royal Free Hospital, Pond Street, Hampstead
-
London, United Kingdom, SE1 7EH
- Guy's and St. Thomas' Trust St.Thomas' Hospital
-
Nuneaton, United Kingdom, CV10 7DJ
- George Elliott Hospital
-
-
Hampstead
-
London, Hampstead, United Kingdom, NW3 2QG
- The Royal Free Hospital, Pond Street, Hampstead
-
-
Lancashire
-
Salford, Lancashire, United Kingdom, M6 8HD
- Hope Hospital
-
-
North Yorkshire
-
Harrogate, North Yorkshire, United Kingdom, HG2 7SX
- Harrogate District Hospital
-
-
Yorkshire
-
Leeds, Yorkshire, United Kingdom, LS1 3EX
- Leeds General Infirmary, Leeds
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Inclusion Criteria:
- 18 years of age or older at time of consent
- Active Psoriatic Arthritis
- Clinically stable, plaque psoriasis involving more than 10% of the body surface area
Exclusion Criteria:
Exclusion Criteria:
- Evidence of skin conditions other than psoriasis that would interfere with skin examinations.
- Systemic anti-psoriasis therapy or DMARD within 28 days of study drug initiation
- Prior exposure to any TNF-inhibitor, including etanercept
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: A
Period 1 (Double Blind): 50mg bi-weekly (BIW) for weeks 1-12.
Period 2 (Open Label): 50 mg weekly (QW).
|
|
|
Active Comparator: B
Period 1 (Double Blind): 50mg weekly (QW) with matching placebo for weeks 1-12.
Period 2 (Open Label): 50 mg weekly (QW) for weeks 13-24.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Patients Achieving "Clear" or "Almost Clear" on Physician Global Assessment (PGA) of Psoriasis
Time Frame: 12 weeks
|
The PGA of Psoriasis scale ranges from 0 (no psoriasis) to 5 (severe disease).
"Clear" and "Almost Clear" includes all patients who were scored as a 0 or 1.
|
12 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Patients Achieving Psoriatic Arthritis Response Criteria (PsARC)
Time Frame: 12 and 24 weeks
|
The PsARC response was defined as improvement in at least 2 of the four criteria: >=30% decrease in swollen joint count, >=30% decrease in tender joint count, >=20% improvement in patient's Global Assessment of Disease Activity (arthritis) using VAS (0-100 mm, 0=excellent and 100= poor), >=20% improvement in physician's Global Assessment of Disease Activity using VAS (VAS: 0-100 mm, 0=no arthritis activity and 100=extremely active arthritis), and at least one of the 2 joint criteria with no deterioration in the other criteria.
|
12 and 24 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
General Publications
- Griffiths CE, Christophers E, Szumski A, Jones H, Mallbris L. Impact of early vs. late disease onset on treatment response to etanercept in patients with psoriasis. Br J Dermatol. 2015 Nov;173(5):1271-3. doi: 10.1111/bjd.13865. Epub 2015 Aug 17. No abstract available.
- Coates LC, Gottlieb AB, Merola JF, Boone C, Szumski A, Chhabra A. Comparison of Different Remission and Low Disease Definitions in Psoriatic Arthritis and Evaluation of Their Prognostic Value. J Rheumatol. 2019 Feb;46(2):160-165. doi: 10.3899/jrheum.180249. Epub 2018 Oct 15.
- Kirkham B, de Vlam K, Li W, Boggs R, Mallbris L, Nab HW, Tarallo M. Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial. Clin Exp Rheumatol. 2015 Jan-Feb;33(1):11-9. Epub 2014 Dec 22.
- Griffiths CE, Sterry W, Brock F, Dilleen M, Stefanidis D, Germain JM, Mallbris L. Pattern of response in patients with moderate-to-severe psoriasis treated with etanercept. Br J Dermatol. 2015 Jan;172(1):230-8. doi: 10.1111/bjd.13139. Epub 2014 Nov 13.
- Gniadecki R, Robertson D, Molta CT, Freundlich B, Pedersen R, Li W, Boggs R, Zbrozek AS. Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens. J Eur Acad Dermatol Venereol. 2012 Nov;26(11):1436-43. doi: 10.1111/j.1468-3083.2011.04308.x. Epub 2011 Oct 31.
- Sterry W, Ortonne JP, Kirkham B, Brocq O, Robertson D, Pedersen RD, Estojak J, Molta CT, Freundlich B. Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial. BMJ. 2010 Feb 2;340:c147. doi: 10.1136/bmj.c147.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Skin Diseases
- Musculoskeletal Diseases
- Skin Diseases, Papulosquamous
- Spinal Diseases
- Bone Diseases
- Spondylarthropathies
- Spondylarthritis
- Spondylitis
- Psoriasis
- Arthritis
- Joint Diseases
- Arthritis, Psoriatic
- Physiological Effects of Drugs
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Immunosuppressive Agents
- Immunologic Factors
- Gastrointestinal Agents
- Etanercept
Other Study ID Numbers
Other Study ID Numbers
- 0881A5-401
- 2005-001533-15 (EudraCT Number)
- B1801271 (Other Identifier: Alias Study Number)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.